Ferre N, Claria J. New insights into the regulation of liver
inflammation and oxidative stress. Mini Rev Med Chem.2006
;6:1321
-1330.
2.
Szabo G, Mandrekar P, Dolganiuc A. Innate immune response and
hepatic inflammation. Semin Liver Dis.2007
;27:339
-350.
3.
Szabo G, Romics L Jr, Frendl G. Liver in sepsis and systemic
inflammatory response syndrome. Clin Liver Dis.2002
;6:1045
-1066.
4.
Zahlten RN, Rogoff TM, Steer CJ. Isolated Kupffer cells,
endothelial cells and hepatocytes as investigative tools for liver research.
Fed Proc. 1981;40:2460
-2468.
5.
Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin
resistance. J Clin Invest.2006
;116:1793
-1801.
6.
Ikejima K, Okumura K, Kon K, Takei Y, Sato N. Role of
adipocytokines in hepatic fibrogenesis. J Gastroenterol
Hepatol. 2007;22(suppl 1): S87-S92.
7.
Decker K. The response of liver macrophages to inflammatory
stimulation. Keio J Med.1998
;47:1
-9.
8.
Kmiec Z. Cooperation of liver cells in health and disease.
Adv Anat Embryol Cell Biol.2001
;161:1
-151.
9.
Anuar F, Whiteman M, Siau JL, Kwong SE, Bhatia M, Moore PK. Nitric
oxide-releasing flurbiprofen reduces formation of proinflammatory hydrogen
sulfide in lipopolysaccharide-treated rat. Br J
Pharmacol. 2006;147:966
-974.
10.
Ulsenheimer A, Gerlach JT, Jung MC, et al. Plasmacytoid dendritic
cells in acute and chronic hepatitis C virus infection.
Hepatology.2005
;41:643
-651.
11.
Koj A, Guzdek A, Potempa J, Korzus E, Travis J. Origin of
circulating acute phase cytokines: modified proteins may trigger IL-6
production by macrophages. Preliminary report. J Physiol
Pharmacol. 1994;45:69
-80.
12.
Jaeschke H, Hasegawa T. Role of neutrophils in acute inflammatory
liver injury. Liver Int.2006
;26:912
-919.
13.
Markiewski MM, DeAngelis RA, Lambris JD. Liver inflammation and
regeneration: two distinct biological phenomena or parallel pathophysiologic
processes? Mol Immunol.2006
;43:45
-56.
14.
Fourel I, Cullen JM, Saputelli J, et al. Evidence that hepatocyte
turnover is required for rapid clearance of duck hepatitis B virus during
antiviral therapy of chronically infected ducks. J
Virol. 1994;68:8321
-8330.
15.
Ysebaert DK, De Greef KE, De Beuf A, et al. T cells as mediators in
renal ischemia/reperfusion injury. Kidney Int.2004
;66:491
-496.
16.
Yang R, Uchiyama T, Watkins SK, Han X, Fink MP. Ethyl pyruvate
reduces liver injury in a murine model of extrahepatic cholestasis.
Shock. 2004;22:369
-375.
17.
Aleffi S, Petrai I, Bertolani C, et al. Upregulation of
proinflammatory and proangiogenic cytokines by leptin in human hepatic
stellate cells. Hepatology.2005
;42:1339
-1348.
18.
De Taeye BM, Novitskaya T, McGuinness OP, et al. Macrophage
TNF-alpha contributes to insulin resistance and hepatic steatosis in
diet-induced obesity. Am J Physiol Endocrinol Metab.2007
;293:E713
-E725.
19.
Grenz A, Schenk M, Zipfel A, Viebahn R. TNF-alpha and its receptors
mediate graft rejection and loss after liver transplantation. Clin
Chem Lab Med. 2000;38:1183
-1185.
20.
Chang S, Dolganiuc A, Szabo G. Toll-like receptors 1 and 6 are
involved in TLR2-mediated macrophage activation by hepatitis C virus core and
NS3 proteins. J Leukoc Biol.2007
;82:479
-487.
21.
McKim SE, Gabele E, Isayama F, et al. Inducible nitric oxide
synthase is required in alcohol-induced liver injury: studies with knockout
mice. Gastroenterology.2003
;125:1834
-1844.
22.
Vrba J, Modriansky M. Oxidative burst of Kupffer cells: target for
liver injury treatment. Biomed Pap Med Fac Univ Palacky Olomouc
Czech Repub. 2002;146:15
-20.
23.
Schwabe RF, Brenner DA. Mechanisms of liver injury. I.
TNF-alpha-induced liver injury: role of IKK, JNK, and ROS pathways.
Am J Physiol Gastrointest Liver Physiol.2006
;290:G583
-G589.
24.
Elsharkawy AM, Mann DA. Nuclear factor-kappaB and the hepatic
inflammation-fibrosis-cancer axis. Hepatology.2007
;46:590
-597.
25.
Hatano E. Tumor necrosis factor signaling in hepatocyte apoptosis.
J Gastroenterol Hepatol.2007
;22(suppl 1):S43
-S44.
26.
Khovidhunkit W, Kim MS, Memon RA, et al. Effects of infection and
inflammation on lipid and lipoprotein metabolism: mechanisms and consequences
to the host. J Lipid Res.2004
;45:1169
-1196.
27.
Bordji K, Grillasca JP, Gouze JN, et al. Evidence for the presence
of peroxisome proliferator-activated receptor (PPAR) alpha and gamma and
retinoid Z receptor in cartilage. PPARgamma activation modulates the effects
of interleukin-1beta on rat chondrocytes. J Biol Chem.2000
;275:12243
-12250.
28.
Chinetti G, Fruchart JC, Staels B. Peroxisome
proliferator-activated receptors (PPARs): nuclear receptors at the crossroads
between lipid metabolism and inflammation. Inflamm
Res. 2000;49:497
-505.
29.
Watanabe M, Houten SM, Mataki C, et al. Bile acids induce energy
expenditure by promoting intracellular thyroid hormone activation.
Nature. 2006;439:484
-489.
30.
Poli G. Pathogenesis of liver fibrosis: role of oxidative stress.
Mol Aspects Med.2000
;21:49
-98.
31.
Albano E. Alcohol, oxidative stress and free radical damage.
Proc Nutr Soc.2006
;65:278
-290.
32.
Duvnjak M, Lerotic I, Barsic N, Tomasic V, Virovic JL, Velagic V.
Pathogenesis and management issues for non-alcoholic fatty liver disease.
World J Gastroenterol.2007
;13:4539
-4550.
33.
Loguercio C, Federico A. Oxidative stress in viral and alcoholic
hepatitis. Free Radic Biol Med.2003
;34:1
-10.
34.
Campbell JS, Riehle KJ, Brooling JT, Bauer RL, Mitchell C, Fausto
N. Proinflammatory cytokine production in liver regeneration is
Myd88-dependent, but independent of Cd14, Tlr2, and Tlr4. J
Immunol. 2006;176:2522
-2528.
35.
John B, Crispe IN. TLR-4 regulates CD8+ T cell trapping in the
liver. J Immunol.2005
;175:1643
-1650.
36.
Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS. TLR4 links
innate immunity and fatty acid-induced insulin resistance. J Clin
Invest. 2006;116:3015
-3025.
37.
Johnson GL, Nakamura K. The c-jun kinase/stress-activated pathway:
regulation, function and role in human disease. Biochim Biophys
Acta. 2007;1773:1341
-1348.
38.
Arkan MC, Hevener AL, Greten FR, et al. IKK-beta links inflammation
to obesity-induced insulin resistance. Nat Med.2005
;11:191
-198.
39.
de Luca C, Olefsky JM. Inflammation and insulin resistance.
FEBS Lett.2008
;582:97
-105.
40.
Rahman SM, Schroeder-Gloeckler JM, Janssen RC, et al.
CCAAT/enhancing binding protein beta deletion in mice attenuates inflammation,
endoplasmic reticulum stress, and lipid accumulation in diet-induced
nonalcoholic steatohepatitis. Hepatology.2007
;45:1108
-1117.
41.
Bataller R, Brenner DA. Hepatic stellate cells as a target for the
treatment of liver fibrosis. Semin Liver Dis.2001
;21:437
-451.
42.
Lalor PF, Sun PJ, Weston CJ, Martin-Santos A, Wakelam MJ, Adams DH.
Activation of vascular adhesion protein-1 on liver endothelium results in an
NF-kappaB-dependent increase in lymphocyte adhesion.
Hepatology.2007
;45:465
-474.
43.
Strazzabosco M, Fabris L, Spirli C. Pathophysiology of
cholangiopathies. J Clin Gastroenterol.2005
;39 (4 Suppl 2):S90
-S102.
44.
Figueiredo FA, De Mello PR, Kondo M. Effect of liver cirrhosis on
body composition: evidence of significant depletion even in mild disease.
J Gastroenterol Hepatol.2005
;20:209
-216.
45.
Mullen KD, Denne SC, McCullough AJ, et al. Leucine metabolism in
stable cirrhosis. Hepatology.1986
;6:622
-630.
46.
McCullough AJ, Mullen KD, Kalhan SC. Defective nonoxidative leucine
degradation and endogenous leucine flux in cirrhosis during an amino acid
infusion. Hepatology.1998
;28:1357
-1364.
47.
Tessari P. Protein metabolism in liver cirrhosis: from albumin to
muscle myofibrils. Curr Opin Clin Nutr Metab Care.2003
;6:79
-85.
48.
Tessari P, Barazzoni R, Kiwanuka E, et al. Impairment of albumin
and whole body postprandial protein synthesis in compensated liver cirrhosis.
Am J Physiol Endocrinol Metab.2002
;282:E304
-E311.
49.
Tessari P, Inchiostro S, Barazzoni R, et al. Fasting and
postprandial phenylalanine and leucine kinetics in liver cirrhosis.
Am J Physiol.1994
;267:E140
-E149.
50.
Dasarathy S, Dodig M, Muc SM, Kalhan SC, McCullough AJ. Skeletal
muscle atrophy is associated with an increased expression of myostatin and
impaired satellite cell function in the portacaval anastamosis rat.
Am J Physiol Gastrointest Liver Physiol.2004
;287:G1124
-G1130.
51.
Dasarathy S, Mullen KD, Conjeevaram HS, Kaminsky-Russ K, Wills LA,
McCullough AJ. Preservation of portal pressure improves growth and metabolic
profile in the male portacaval-shunted rat. Dig Dis
Sci. 2002;47:1936
-1942.
52.
Dasarathy S, Muc S, Hisamuddin K, et al. Altered expression of
genes regulating skeletal muscle mass in the portacaval anastomosis rat.
Am J Physiol Gastrointest Liver Physiol.2007
;292:G1105
-G1113.
53.
Tiberio L, Tiberio GA, Bardella L, et al. Mechanisms of
interleukin-6 protection against ischemia-reperfusion injury in rat liver.
Cytokine. 2006;34:131
-142.
54.
Jaeschke H. Mechanisms of liver injury. II. Mechanisms of
neutrophil-induced liver cell injury during hepatic ischemia-reperfusion and
other acute inflammatory conditions. Am J Physiol Gastrointest
Liver Physiol. 2006;290:G1083
-G1088.
55.
Cover C, Liu J, Farhood A, et al. Pathophysiological role of the
acute inflammatory response during acetaminophen hepatotoxicity.
Toxicol Appl Pharmacol.2006
;216:98
-107.